Cargando…

MiR-139 Modulates Cancer Stem Cell Function of Human Breast Cancer through Targeting CXCR4

SIMPLE SUMMARY: The C-X-C motif chemokine receptor 4 (CXCR4) is overexpressed in various cancer stem/progenitor cells via activation of the epithelial-mesenchymal transition (EMT) program to facilitate tumor cell aggressiveness in the premetastatic niche. Through miRNAs microarray and bioinformatics...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Chun-Wen, Liao, Wen-Ling, Chen, Po-Ming, Yu, Jyh-Cherng, Shiau, Hui-Ping, Hsieh, Yi-Hsien, Lee, Huei-Jane, Cheng, Yu-Chun, Wu, Pei-Ei, Shen, Chen-Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198393/ https://www.ncbi.nlm.nih.gov/pubmed/34070538 http://dx.doi.org/10.3390/cancers13112582

Ejemplares similares

Tumor-suppressor role of miR-139-5p in endometrial cancer
por: Liu, JinHui, et al.
Publicado: (2018)

Soy Isoflavone Genistein Impedes Cancer Stemness and Mesenchymal Transition in Head and Neck Cancer through Activating miR-34a/RTCB Axis
por: Hsieh, Pei-Ling, et al.
Publicado: (2020)

Regulation of Oncogenic Targets by the Tumor-Suppressive miR-139 Duplex (miR-139-5p and miR-139-3p) in Renal Cell Carcinoma
por: Okada, Reona, et al.
Publicado: (2020)

The prognostic significance of RUNX2 and miR-10a/10b and their inter-relationship in breast cancer
por: Chang, Chih-Hao, et al.
Publicado: (2014)

Induction of G2/M Phase Arrest by Diosgenin via Activation of Chk1 Kinase and Cdc25C Regulatory Pathways to Promote Apoptosis in Human Breast Cancer Cells
por: Liao, Wen-Ling, et al.
Publicado: (2019)

MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer
por: Chang, Chia-Wei, et al.
Publicado: (2016)

Dual tumor‐suppressors miR‐139‐5p and miR‐139‐3p targeting matrix metalloprotease 11 in bladder cancer
por: Yonemori, Masaya, et al.
Publicado: (2016)

H19 Overexpression Improved Efficacy of Mesenchymal Stem Cells in Ulcerative Colitis by Modulating the miR-141/ICAM-1 and miR-139/CXCR4 Axes
por: Zhao, Ming-li, et al.
Publicado: (2021)

Genetic variation in the genome-wide predicted estrogen response element-related sequences is associated with breast cancer development
por: Yu, Jyh-Cherng, et al.
Publicado: (2011)

Andrographolide impedes cancer stemness and enhances radio-sensitivity in oral carcinomas via miR-218 activation
por: Yang, Po-Yu, et al.
Publicado: (2016)

miR-1246 Targets CCNG2 to Enhance Cancer Stemness and Chemoresistance in Oral Carcinomas
por: Lin, Shih-Shen, et al.
Publicado: (2018)

miR-21 promotes the fibrotic properties in oral mucosa through targeting PDCD4
por: Liao, Yi-Wen, et al.
Publicado: (2022)

The role of miR-139-5p in radioiodine-resistant thyroid cancer
por: Pecce, V., et al.
Publicado: (2023)

Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer
por: Ng, Lui, et al.
Publicado: (2017)

Baicalein Induces Apoptosis of Pancreatic Cancer Cells by Regulating the Expression of miR-139-3p and miR-196b-5p
por: Ma, Danhui, et al.
Publicado: (2021)

LINC00084/miR-204/ZEB1 Axis Mediates Myofibroblastic Differentiation Activity in Fibrotic Buccal Mucosa Fibroblasts: Therapeutic Target for Oral Submucous Fibrosis
por: Lee, Yu-Hsien, et al.
Publicado: (2021)

Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in erk-responsive lung cancer
por: Cheng, Chun-Wen, et al.
Publicado: (2015)

miR-139-5p is a regulator of metastatic pathways in breast cancer
por: Krishnan, Keerthana, et al.
Publicado: (2013)

Potential role of miR-139-5p in cancer diagnosis, prognosis and therapy
por: Huang, Ling-Li, et al.
Publicado: (2017)

MicroRNA 139-5p coordinates APLNR-CXCR4 crosstalk during vascular maturation
por: Papangeli, Irinna, et al.
Publicado: (2016)

Butylidenephthalide Abrogates the Snail-Induced Cancer Stemness in Oral Carcinomas
por: Chen, Pei-Yin, et al.
Publicado: (2022)

miR-509 inhibits cancer stemness properties in oral carcinomas via directly targeting PlK1
por: Lu, Ming-Yi, et al.
Publicado: (2022)

miR‐200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2
por: Liao, Yi‐Wen, et al.
Publicado: (2018)

Role of miR-139-5p in ectopic endometrial stromal cells and the underlying molecular mechanism
por: Feng, Lixia, et al.
Publicado: (2021)

ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting miR-185
por: Tan, Bibo, et al.
Publicado: (2018)

Predictive values of miR-129 and miR-139 for efficacy on patients with prostate cancer after chemotherapy and prognostic correlation
por: Hu, Zhongchun, et al.
Publicado: (2019)

Inactivation of oncogenic cAMP-specific phosphodiesterase 4D by miR-139-5p in response to p53 activation
por: Cao, Bo, et al.
Publicado: (2016)

Serum Exosome-Derived miR-139-5p as a Potential Biomarker for Major Depressive Disorder
por: Liang, Jia-Quan, et al.
Publicado: (2020)

miR-486-3p, miR-139-5p, and miR-21 as Biomarkers for the Detection of Oral Tongue Squamous Cell Carcinoma
por: Chen, Zujian, et al.
Publicado: (2017)

miR-486-3p, miR-139-5p, and miR-21 as Biomarkers for the Detection of Oral Tongue Squamous Cell Carcinoma
por: Chen, Zujian, et al.
Publicado: (2017)

Impact of Oncogenic Targets by Tumor-Suppressive miR-139-5p and miR-139-3p Regulation in Head and Neck Squamous Cell Carcinoma
por: Koma, Ayaka, et al.
Publicado: (2021)

LncRNA C9orf139 can regulate the growth of pancreatic cancer by mediating the miR-663a/Sox12 axis
por: Ge, Jin-Nian, et al.
Publicado: (2020)

MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer
por: Miyoshi, Jinsei, et al.
Publicado: (2017)

Expression and clinical significance of miR-139-5p in non-small cell lung cancer
por: Yong-hao, You, et al.
Publicado: (2019)

MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52
por: Li, Yuanbo, et al.
Publicado: (2022)

Targeting lncRNA H19/miR-29b/COL1A1 Axis Impedes Myofibroblast Activities of Precancerous Oral Submucous Fibrosis
por: Yu, Cheng-Chia, et al.
Publicado: (2021)

Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1
por: Wang, Lei, et al.
Publicado: (2021)

MiR-139-5p negatively regulates PMP22 to repress cell proliferation by targeting the NF-κB signaling pathway in gastric cancer
por: Hou, Jingjing, et al.
Publicado: (2020)

miR-139-5p and miR-451a as a Diagnostic Biomarker in LUSC
por: Gao, Bo, et al.
Publicado: (2023)

Tumor-Suppressive Function of miR-139-5p in Esophageal Squamous Cell Carcinoma
por: Liu, Ran, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_880ciqtfnkgilqfet62v4jj0n9